Asieris Pharmaceuticals Announces 2021 Annual Report: Steady Progress in Core Product Pipeline and Progressive Implementation of the Integrated Diagnosis and Tr

SHANGHAI, April 14, 2022 /PRNewswire/ — Asieris Pharmaceuticals (688176.SH), a global innovative pharmaceutical company specializing in the treatment of genitourinary...

Related Keywords

Germany ,Australia ,Shanghai ,China ,Hungary ,Netherlands ,Czech Republic ,Poland ,Ukraine ,Chinese ,Boao Lecheng ,Kevin Pan ,Asieris Pharmaceuticals ,Innovation In Integrated Diagnosis Treatment Solutions ,Sinopharm Group ,Asieris Pharmaceutical ,Prodrug Accurate Drug Delivery ,Integrated Diagnosis ,Treatment Solutions ,Accelerated Commercialization ,Hainan Province ,Bo Ao Lecheng National Pilot Zone ,International Medical ,Healthy Financial ,